| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $1.06B | +41.0% |
| Cost of Revenue | $185.5M | +112.0% |
| Gross Profit | $870.3M | +31.6% |
| R&D Expense | $1.03B | +37.1% |
| SG&A Expense | $555.5M | +75.9% |
| Operating Income | -$1.29B | -47.1% |
| Pre-tax Income | -$1.23B | -54.5% |
| Income Tax | $24.8M | +140.7% |
| Net Income | -$1.25B |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $403.5M | -17.1% |
| Short-term Investments | $1.25B | +29.0% |
| Accounts Receivable | $247.9M | +88.8% |
| Current Assets | $2.00B | +22.4% |
| Total Assets | $2.35B | +31.0% |
| Current Liabilities | $776.1M | +73.6% |
| Total Liabilities | $837.6M | +78.5% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $250.7M | +506.2% |
| Capital Expenditures | $4.4M | +124.8% |
| Investing Cash Flow | -$371.4M | +52.6% |
| Financing Cash Flow | $43.3M | -30.6% |
| Free Cash Flow | $246.2M | +486.6% |
| -70.8% |
| EPS (Basic) | -$3.71 | +0.8% |
| EPS (Diluted) | -$3.71 | +0.8% |
| Stockholders' Equity |
| $1.51B |
| +14.1% |